Shenglan Qi
Impact in
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacological Effects of Natural Compounds
- Berberine and alkaloids research
-
- Medicinal Plants and Neuroprotection
Papers in
-
- Synthesis and bioactivity of alkaloids 6
- Metabolomics and Mass Spectrometry Studies 3
-
- Cholinesterase and Neurodegenerative Diseases 3
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Changhong Wang (12 shared papers)Xuemei Cheng (8 shared papers)Wei Liu (6 shared papers)Chao Ma (4 shared papers)Huida Guan (5 shared papers)Gang Deng (2 shared papers)Shuping Li (1 shared paper)Ping Liu (6 shared papers)
- Journals
- Journal of Ethnopharmacology (8 papers)Frontiers in Pharmacology (4 papers)International Journal of Biological Macromolecules (2 papers)Phytomedicine (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Shenglan Qi
25 papers receiving 338 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 54
- Complementary and alternative medicine 47
- Pharmacology 95
- Biological Psychiatry 11
- Hepatology 26
Countries citing papers authored by Shenglan Qi
This map shows the geographic impact of Shenglan Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Qi more than expected).
Fields of papers citing papers by Shenglan Qi
This network shows the impact of papers produced by Shenglan Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Qi. The network helps show where Shenglan Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Shenglan Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 107 | |
| 2 | 2017 | 29 | |
| 3 | 2023 | 27 | |
| 4 | 2022 | 21 | |
| 5 | 2017 | 18 | |
| 6 | 2023 | 17 | |
| 7 | 2015 | 16 | |
| 8 | 2018 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2023 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2024 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2025 | 3 |
About Shenglan Qi
Shenglan Qi is a scholar working on Molecular Biology, Pharmacology, Epidemiology, Pharmacology and Hepatology, having authored 29 papers that have together received 345 indexed citations. Recurring topics across this work include Synthesis and bioactivity of alkaloids (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Liver Diseases and Immunity (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Chemical synthesis and alkaloids (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Pharmacology (54 citations), Complementary and alternative medicine (47 citations), Pharmacology (95 citations), Biological Psychiatry (11 citations) and Hepatology (26 citations). Shenglan Qi has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Changhong Wang, Xuemei Cheng, Wei Liu, Chao Ma, Huida Guan, Gang Deng, Shuping Li, Ping Liu, Qiyan Lin and Wenzheng Ding. Their work appears in journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology, International Journal of Biological Macromolecules, Phytomedicine and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.